Events

Talk at the Annual Conference of Autophagy DRIVE Consortium

Benoît de Chassey gave a talk entitled: “From Virus-Host Interactomes To Drug Discovery” at the Annual Conference of Autophagy DRIVE Consortium (Driving next generation autophagy researchers towards translation) coordinated by Pr Fulvio Reggiori.

Read more »

Immunotherapies & Innovations for Infectious Diseases Congress 2020

December 9-10, 2020
Digital Edition

ENYO will attend the 4th edition of I4ID congress. The purpose of this two-day congress is to foster interactions between pharmaceutical industries, research labs, service providers, technology developers, and clinicians, thereby contributing to the development of innovative strategies against infectious diseases in a multidisciplinary approach.

Read more »

AASLD 2020

13-16 November, 2020
Digital edition

ENYO Pharma attended the 2020 digital edition of AASLD meeting.

The meeting confirms vonafexor (EYP001, FXRag) unique positioning for HBV and possible differentiated profile for NASH with ph2s on track to deliver in H1 2021.

We also presented a poster describing a novel small molecule modulating the mitochondrial NEET proteins that improves inflammation and fibrosis in liver and kidneys of NASH mice :

Read more »

American Society of Nephrology – Kidney Week 2020

ENYO Pharma is present at the digital Kidney Week 2020 organized by the ASN with a poster. ASN has been honored to host the world’s premier meeting in nephrology for 50+ years, which has been “Reimagined” as a fully digital meeting.

“A novel small molecule modulating the mitochondrial NEET proteins improves inflammation and fibrosis in kidneys of NASH mice”

Read more »

Selection for international MATWIN board

Digital meeting
13-14 October, 2020

MATWIN (Maturation & Accelerating Translation within Industry) is an innovation platform that aims to accelerate transfer of oncology innovation from academia & SMEs to clinical development. 13 Pharma partners and numerous academic opinion leaders review proposals for partnership opportunities that offer most promise for patient well being. ENYO Pharma project is selected for a pitch to participating VC investors for start-up funds.

Read more »